07:00 , Mar 19, 2007 |  BioCentury  |  Finance

Ebb & Flow

Two new companies, Tragara Pharmaceuticals and Epiphany Biosciences , landed large series A rounds last week. Each was formed around recently in-licensed compounds and hopes to get to a major value inflection point, Phase IIb...
07:00 , Jul 25, 2005 |  BioCentury  |  Strategy

European takeouts

European takeouts Completed Acquirer Country Acquired Country Value Jan Paradigm Therapeutics U.K. Amedis U.K. Undisclosed Jan Sinclair Pharma (LSE:SPH) U.K. Euroderm RDC Italy E6M ($7.2M) in cash & stock Jan Solvay (Euronext:SOLB) Belgium NeoPharma Sweden...
08:00 , Jan 17, 2005 |  BC Week In Review  |  Company News

Amedis, Paradigm Thera deal

Paradigm acquired Amedis for an undisclosed amount of stock. The deal combines Amedis' medicinal and silicon chemistry capabilities with Paradigm's targets and in vivo genomics technology. Amedis also has two preclinical programs in development for...
08:00 , Jan 20, 2003 |  BC Week In Review  |  Company News

Argenta Discovery, Amedis deal

Argenta will use Amedis's AI platform, an artificial intelligence technology for the prediction of drug properties and the chemical modification of compounds to enhance drug-like properties, with its own drug discovery processes. Argenta Discovery Ltd....
07:00 , Sep 23, 2002 |  BC Week In Review  |  Company News

Amedis management update

Amedis Pharmaceuticals Ltd. , Cambridge, U.K.   Business: Chemistry   Hired: Malcom Hay as finance director, formerly finance director of Allergy Therapeutics Ltd.  ...
07:00 , Jul 29, 2002 |  BC Week In Review  |  Company News

Amedis management update

Amedis Pharmaceuticals Ltd. , Cambridge, U.K.   Business: Chemistry   Hired: Graham Showell as director of chemistry, formerly director of discovery chemistry at Millennium Pharmaceuticals Inc.  ...
07:00 , Jun 24, 2002 |  BC Week In Review  |  Company News

Argenta Discovery, Amedis deal

Argenta and Amedis partnered to create small molecule inhibitors of protease enzymes to develop treatments against cancer and bacterial and viral infections. Argenta Discovery Ltd. , Harlow, U.K.   Amedis Pharmaceuticals Ltd. , Cambridge, U.K....
07:00 , Jun 19, 2002 |  BC Extra  |  Company News

Argenta, Amedis protease enzyme deal

Argenta Discovery (Harlow, U.K.) and Amedis Pharmaceuticals (Cambridge, U.K.) partnered to create small molecule inhibitors of protease enzymes to develop treatments against cancer and bacterial and viral infections....
07:00 , Apr 29, 2002 |  BC Week In Review  |  Company News

Amedis board of directors update

Amedis Pharmaceuticals Ltd. , Cambridge, U.K.   Business: Chemistry   Appointed: Edwin Moses, director at Evotec OAI, as chairman  ...
07:00 , Apr 29, 2002 |  BC Week In Review  |  Company News

Amedis management update

Amedis Pharmaceuticals Ltd. , Cambridge, U.K.   Business: Chemistry   Hired: John Montana as CEO, formerly director of new chemical entity research at Celltech Group plc  ...